Last Updated: May 26, 2016
- Ephedrine injection, Nexus Pharmaceuticals, 50 mg/mL, 1 mL vial, 10 count, NDC 14789-0014-01
- Ephedrine injection, Sandoz, 50 mg/mL, 1 mL vial, 25 count, NDC 66758-0008-02
- Hospira discontinued ephedrine in March, 2011.
- Nexus exited the market for ephedrine injection in 2015.
- Sandoz discontinued ephedrine in summer 2015.
- Ephedrine injection, Akorn, 50 mg/mL, 1 mL ampule, 10 count, NDC 17478-0515-00
Estimated Resupply Dates
- All marketed presentations are currently available.
Updated May 26, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Created March 18, 2014 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.